LITTLE KNOWN FACTS ABOUT NUC-7738.

OMEPRAZOLE: There have been no alterations while in the pharmacokinetic parameters of both cerivastatin or its main active metabolites, or of omeprazole in wholesome youthful males specified solitary 0.3 mg oral doses of cerivastatin alone or on the fifth working day of a 5-day omeprazole twenty mg day-to-day pre-treatment method.Rhabdomyolysis wit